Interpretation of HER2 Immunohistochemistry (IHC): Agilent Dako HercepTest™

The page below is a sample from the LabCE course HER2 Testing in Breast Cancer. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about HER2 Testing in Breast Cancer (online CE course)
Interpretation of HER2 Immunohistochemistry (IHC): Agilent Dako HercepTest™

Scoring guidelines are given by Agilent Dako in the Food and Drug Administration (FDA) approved package insert as follows:
ScoreInterpretationDefinition
0NegativeNo staining is observed OR membrane staining is in less than 10% of tumor cells.
1+NegativeA faint, barely perceptible membrane staining is detected in more than 10% of tumor cells. However, only part of the membrane is staining.
2+PositiveA weak to moderate complete membrane staining is observed in more than 10% of the tumor cells.
3+PositiveA strong complete membrane staining is observed in more than 10% of tumor cells.